Lysyl oxidase (LO) (E.C.1.4.3.13), a copper-dependent enzyme, oxidizes peptidyl lysine residues in substrates, e.g., collagen, elastin, and histone H1, essential for organization and stabilization of the extracellular matrix (ECM) and the cell nucleus (Kagan and Li, 2003; Li et al., 2011) . Of particular interest, considerable evidence supports LO as a tumor suppressor. This catalyst has been shown to antagonize transforming activity of ras, a proto-oncogene (Kenyon et al., 1991) . Defected expression of LO was detected in a variety of spontaneous tumors in humans (Li et al., 2011) . Thus, LO as an intra-and extracellular effector is implicated in various human pathological states such as organ fibrosis, atherosclerosis, emphysema, carcinogenesis, etc. (Kagan and Li, 2003; Li et al., 2011) .
Hypoxia is a profibrotic stimulus, which enhances the expression of LO and its substrates such as collagen in different assay systems (Higgins et al., 2008; Manalo et al., 2005) . Furthermore, high levels of LO were also detected in the hypoxia stage of some tumors, facilitating the metastasis (Erler et al., 2006) . Hypoxia-inducible factor-1 (HIF-1), a transcription enhancer, plays a critical role in the cell response to oxygen deficiency (Kaluz et al., 2008) . The HIF-1 is composed of HIF-1α and HIF-1β subunits. The HIF-1β is constitutively expressed, whereas HIF-1α is maintained at a low level in normoxic cells. Upon hypoxia, HIF-1α is upregulated and HIF-1 complex binds to the hypoxia-response element (HRE) of the gene promoter for transactivation.
Cobalt (Co), an essential metal for the formation of vitamin B12, mimics the hypoxia condition in the cell culture system activating the HIF-1 targeting genes (Kaluz et al., 2008) . Cadmium (Cd) is a toxic carcinogen without any biological availability (Li et al., 2011) . Cd exposure enhances cellular levels of reactive oxygen species (ROS) (Cuypers et al., 2010) . To elucidate regulation of LO gene transcription under hypoxia conditions, we used the cloned 804 base pair rat LO promoter with the maximal promoter activity as a model (Gao et al., 2007) to characterize HRE status in the LO gene under Co exposure conditions. Furthermore, we also examined Co-activated LO promoter in response to Cd, a ROS inducer in the biological system. We found that only one HRE mapped at −387/−383 relative to ATG was functionally active in response to Co among four HRE consensuses existing in the cloned LO promoter, and Cd inhibited HIF-1α expression and its binding to the HRE for Co activation of the LO gene.
Transient transfection and luciferase assay. Cell transfection and assays for reporter gene products were carried out as described previously (Gao et al., 2007) . Briefly, RFL6 cells were plated at 2.5 × 10 5 cells per 35-mm well containing 2 ml of 10% FBS/DMEM. After 24-h incubation, cells were cotransfected with LO promoter-luciferase constructs prepared by this lab (1 µg) (Gao et al., 2007) and phRL-TK expression vectors (0.5 µg; Promega, Madison, WI), the latter used as an internal control to monitor the transfection efficiency, by using lipofectamine reagent (Invitrogen). Following 6 h posttransfection incubation, cells were immersed in 10% FBS/DMEM for 18 h, washed, and then changed to 0.3% FBS/DMEM for 6 h. Such prepared cells were finally treated with or without different concentrations of Co for an additional 24 h. The luciferase activity in the cell lysates was determined using dual luciferase assay reagents (Promega). The luciferase activities were normalized by the internal control values and represented as the mean ± SD for the three wells. For the transient overexpression assays in RFL6 cells, 0.5 µg of each expression vector was cotransfected together with the luciferase reporter vectors. After incubation for 18 h, the medium was replaced with a 0.3% FBS/DMEM, and 6 h later, these cells were treated with or without Co at indicated concentrations for an additional 24 h.
Nuclear extract preparation and EMSA. Nuclear extracts were prepared from control and Co-treated cells using Nuclear and Cytoplasmic Extraction kit (Pierce, Rockford, IL). Protein concentrations were determined by the BCA protein assay reagents (Pierce). For the EMSA (Gao et al., 2007) , synthetic oligonucleotides were end labeled with [γ-32 P]ATP (Perkin Elmer, Boston, MA) by T4 polynucleotide kinase (New England Biolabs, Boston, MA) and annealed to their complements. A total volume of 20 µl reaction mixture containing 20 µg of nuclear protein or bovine serum albumin, a negative control, 1 µg of poly(dIdC).poly(dI-dC) (Sigma, St Louis, MO), and 10,000 to 20,000 cpm of labeled probes was incubated for 20 min at room temperature. For competition experiments, cold human erythropoietin (Epo) HRE oligonucleotides as described (Mukhopadhyay et al., 2000) at 100-fold molecular excess were added 10 min prior to addition of the radiolabeled probe. After reaction, samples were subjected to native 6% polyacrylamide gel electrophoresis and visualized by exposure of the dried gel to Kodak film. Supershift reactions were run as competition assays as described above with the exception that 2 µg of a specific antibody against HIF-1α (Santa Cruz Biotech) instead of cold probes was added.
In vitro transcription/translation. The rat HIF-1α, HIF-1β, and DN-HIF-1α proteins were expressed by PCR based on the methodology of in vitro transcription/translation in rabbit reticulocyte lysates (Promega) according to the manufacturer's instruction. The primer pairs are 5′-GGATCCTAATACGAC  TCACTATAGGGAACAGCCACCATGGAGGGCG CCGGCGGCGAGAA-3′  and 5′-TTTTTTTTTTTTTTTTTTTTTTTTTT TTTTTTTTAGTTAACTTGA-TCCAAAGCTCTG-3′ for HIF-1α, 5′-GGATCCTAATACGACTCA CTA-TAGGGAACAGCCA CCATGGCGGCGACTACAGCTAACC-3′  and  5′-TTTTTTTTTTTTTTTTTTTTTTTTTT TTTTTTTATTCAGAAAAAG  GGGGAAACA-3′ for HIF-1β, and 5′-GGATCCTAATACGACTCACTA-AGG GAACAGCCACCAT GCGAAGCAAAGAGTCTGAAG-3′  and  5′-TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT TTAAAGCTT GTC GAA-GAGGCAGCTC-3′ for DN-HIF-1α.
Site-directed mutagenesis. The mutated HRE in the LO promoter-reporter construct was created by site-directed mutagenesis using the QuickChangeTM SiteDirected Mutagenesis Kit (Stratagene, La Jolla, CA). The pLOProm 804-reporter construct was used as a parental plasmid containing the wild-type HRE (labeled with the lower bold case), i.e., 5′-GCTGTCCGCCTTGcacgtTTCCAATCGCAT-3′ as described (Gao et al., 2007) . Primers used for the point mutation is 5′-GGAGCTGTCCGCCTTGcgattTTCCAATCGCATTACG-3′, where the HRE and mutated nucleotides were labeled with the lower bold case and underline, respectively.
Chromatin immunoprecipitation assay.
To determine cellular HIF-1 binding to the LO promoter region, the chromatin immunoprecipitation (ChIP) assay was performed as described (Gao et al., 2007) with the EpiQuik Chromatin Immunoprecipitation Kit based on the protocol provided by the supplier (Epigentek Group Inc., Brooklyn, NY). Cellular components were crosslinked by incubation of control and metal (Co, Cd, or both)-treated cells at the same number (2 × 10 6 ) with 1% formaldehyde. The crosslinking reaction was stopped by addition of glycine. Nuclei were extracted and then sonicated to shear DNA to lengths between 200 and 1000 bp. After centrifugation, aliquots of DNA containing supernatants were removed out as "input" DNA. DNA samples were transferred into the strip wells precoated with the antibody against rat HIF-1α, (Santa Cruz Biotech), RNA-Poly II (a positive control provided by the kit supplier), or nonspecific rat IgG (a negative control from Santa Cruz Biotech). After incubation followed by successive washing, precipitated DNA-protein complexes and the "input" samples were treated with proteinase K and collected by the P-spin columns. Using purified DNA as a template, PCR was conducted under conditions as described (Gao et al., 2007) . Primer pairs were used in PCR to characterize the HIF-1α binding to the LO gene and the RNA-Poly II binding to GAPDH gene as follows: 5′-CTC-CCTGTGCAACGTGTCT-3′ and 5′-TGCAGTTACACAAGCCGTTC-3′ were used for amplification of the LO HRE fragment (152 bp), and 5′-TTGCTTG-GCTTCTTCTTTGG-3′ and 5′-GAGACGAGGCTGGTACTCCA-3′ were used for amplification of the RNA-Poly II binding region in the GAPDH promoter (160 bp). PCR products were analyzed on a 2.2% agarose gel, stained with 380 ethidium bromide and visualized on a UV transilluminator. Densities of DNA bands on the gel were measured as described (Chen et al., 2005) .
Statistical analysis. Data were expressed as mean ± SD of at least three independent experiments. Statistical differences between means were determined using one-way ANOVA followed by Bonferroni's post hoc test or two-tailed Student's t-test when appropriate. A p value < 0.05 was considered significant.
RESuLTS

Co Enhanced LO mRNA Levels and Promoter Activities in Treated RFL6 Cells
To assess hypoxia effects on the expression of the LO gene, we first examined LO mRNA levels in RFL6 cells in response to various dosages of Co, which mimics the hypoxia condition in the cell culture system (Kaluz et al., 2008) . As shown in Figure 1A , exposure of cells to CoCl 2 induced a dose-dependent enhancement of LO mRNA expression as determined by the RT-PCR reaching 144, 162, and 188% of the control in cells exposed to Co at 10, 30, and 100 µM concentrations, respectively. To answer the question whether enhancement of LO mRNA expression by Co is due to activation of the LO gene promoter, we have prepared a LO promoter-reporter construct containing a 804 bp LO gene promoter fragment relative to the translation initiation codon ATG upstream of the luciferase gene in the pGL3-Basic vector (Promega) (pLOProm 804) (Gao et al., 2007) . The pLOProm 804 construct and the phRL-TK vector, an internal control, were transiently cotransfected into RFL6 cells. Effects of CoCl 2 at different concentrations on the reporter gene product expression were tested. As shown in Figure 1B , Co exposure increased luciferase activities amounting to 1.4-, 1.9-, and 2.9-fold of the control, respectively, in cells treated with Co at 10, 30, and 100 µM concentrations. Thus, LO is a Co/hypoxia-sensitive gene.
Co Enhancement of the LO Promoter Activity via Stimulation by HIF-1
HIF-1 is a major transcription factor for the gene activation by hypoxia (Kaluz et al., 2008) . To test whether the HIF-1 is involved in Co-induced LO gene expression in RFL6 cells, we examined effects of increased cellular level of HIF-1 by using gene expression vectors, i.e., the pcDNA3.1-HIF-1α, 804) and phRL-TK vector, an internal control, then exposed to Co at indicated concentrations for 24 h. Luciferase activity in each treatment was normalized to the internal control and expressed as % of the control without Co treatment. *p < 0.05, **p < 0.01, and ***p < 0.001 relative to control.
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pcDNA3.1-HIF-1β, or both, on expression of the LO promoterdriven reporter gene. Cells were cotransfected with the LO promoter-reporter construct (pLOProm 804), different HIF-1 expression vectors and the internal control phRL-TK vector, and incubated under normoxia and Co exposure conditions. As shown in Figure 2 , overexpression of HIF-1α and HIF-1α + HIF-1β, but not HIF-1β alone, in the absence of 100 µM Co, increased LO promoter-driven luciferase activity by 2.2-and 2.8-fold, respectively, compared with cells expressing the basic reporter only under normoxia. However, when cells were cotransfected with HIF-1α and HIF-1α + HIF-1β expression vectors in the presence of 100 µM Co, LO promoter-driven reporter gene expression increased to 3.9-and 7.2-fold of the basal control, respectively. It should be noted that a 2.5-fold increase of the LO promoter-driven reporter gene expression in pcDNA3.1 cotransfected cells in the presence of Co reflected effects of cell endogenous HIF-1 activation by this metal ion consistent with data as shown in Figure 1B . These data support that transactivation of the LO gene by Co is mediated by activation by HIF-1, and overexpression of HIF-1α plus HIF-1β had an additive effect on the maximal LO promoter activation in cells treated with Co or hypoxia conditions.
DN-HIF-1α Inhibited LO Promoter Activity Stimulated by Co
To illustrate the specificity of the HIF-1 in transactivating the LO promoter by Co, RFL6 cells were cotransfected with the LO promoter-reporter construct (pLOProm 804) and the DN-HIF-1α expression vector (Grosfeld et al., 2002) as well as the internal control phRL-TK vector. Transfected cells were then incubated in the presence or absence of Co at 100 µM for 24 h. The DN-HIF-1α mutant without the DNA binding domain can heterodimerize with HIF-1β to form an inactive dimer, thus inhibiting the activation of the HRE containing gene (Richard et al., 2000) . As shown in Figure 3 , overexpression of the DN-HIF-1α decreased luciferase activities to 25% of the control in cells treated with Co. These results further demonstrated the efficiency of the DN-HIF-1α in inhibition of LO promoter activity via the HIF-1 pathway in Co-treated RFL6 cells.
Overexpression of LO mRNA Was Associated With Upregulation of Cellular HIF-1a mRNA in Co-Treated RFL6 Cells
To establish the relationship between LO and HIF-1 expressions in Co-exposed cells, we examined their mRNA levels in control and Co-exposed cells. Total RNA samples were prepared from RFL6 cells incubated in the presence or absence of 100 µM Co. As shown in Figure 4 , cellular HIF-1α mRNA was at a very low level with the density of 0.21 in the normoxia condition without Co treatment but had a higher level of expression in Co-treated condition reaching 51-fold of the control (compare lane 6 with lane 1). Concomitantly, LO mRNA was significantly increased in cells treated with 100 µM Co amounting to 1.78-fold of the control under the normoxia condition (compare lane 9 with lane 4). However, HIF-1β mRNA did not display a noticeable change in Co treatment condition compared with normoxia condition. The DN-HIF-1α had a higher expression level either in normoxia or in Co treatment condition. There was   FIG. 3 . DN-HIF-1α inhibition of the LO promoter activity stimulated by Co in RFL6 cells. Cells were cotransfected with the LO promoter-reporter construct (pLOProm 804) and DN-HIF-1α expression vectors and the internal control phRL-TK vector, then treated without or with 100 µM Co for 24 h. Luciferase activity in each treatment was normalized to the internal control and expressed as % of the control in which cells were cotransfected with the pcDNA3.1 basic vector without the DN-HIF-1α cDNA insert. ***p < 0.001 relative to control cells cotransfected with the pcDNA3.1 basic vector without the DN-HIF-1α cDNA insert and treated with Co.
FIG. 2.
Co enhancement of the LO promoter activity stimulated by HIF-1 in treated RFL6 cells. Cells were cotransfected with the LO promoter-reporter construct (pLOProm 804) and different HIF-1 expression vectors as shown, as well as the internal control phRL-TK vector, then treated without or with 100 µM Co for 24 h. Luciferase activity in each treatment was normalized to the internal control and expressed as % of the control in which cells were cotransfected with the pcDNA3.1 basic vector without the HIF-1 cDNA insert. *p < 0.05 and ***p < 0.001 relative to control cells cotransfected with the pcDNA3.1 basic vector. 382 no significant difference between both treatment conditions in GAPDH mRNA levels. These data suggest that HIF-1α was transactivated only upon Co treatment in association with upregulation of LO, whereas HIF-1β is constitutively expressed in both normoxia and Co treatment conditions. Higher expression of the DN-HIF-1α in both control and Co-treated cells suggests its potential regulatory effects on HRE activation or suppression.
Identification of HIF-1 Binding Sites in the 804 bp LO Promoter Fragment
Sequence analysis reveals the presence of four 5′-RCGTG-3′ HIF-1 binding consensuses (HRE) within the 804 bp LO promoter fragment upstream of ATG. Three putative HREs located at −33/−37, −190/−194, and −383/−387 are on the noncoding strand, and the fourth HRE located at −457/−453 is on the coding strand (Fig. 5) . To determine whether HIF-1 binds to the functional HRE sequences in the LO gene, we performed EMSAs using four [ 32 P]-labeled 30-bp probes encompassing each putative HRE sequence in the LO 804 bp promoter (HRE-1, HRE-2, HRE-3, and HRE-4) (Fig. 6A) . The shifted band was observed only using the radiolabeled HRE-3 probe in the presence of nuclear extracts from Co-treated cells (Fig. 6B , lane 9) but not that from the normoxic cells (Fig. 6B, lane 8) , and no obvious shifted bands were observed using HRE-1, HRE-2, or HRE-4 probes under either normoxia or Co-treated condition (Fig. 6B) . These results suggest that the HIF-1 complex binds to the HRE-3 sequence under Co chemical hypoxia condition. To confirm that the shifted band by the HRE-3 probe is a HIF-1 binding site, we performed a competition assay. As shown in Figure 6C , with a 100-fold molar excess of unlabeled human Epo HRE oligonucleotides (Mukhopadhyay et al., 2000) , the binding of the radiolabeled HRE-3 probe with HIF-1 from nuclear extract of Co-treated cells was suppressed effectively (compare lane 4 with lane 3). This provides the evidence that the HRE-3 site is a target for HIF-1 binding under Co mimic hypoxia condition. Furthermore, we also assess whether HRE elements in the 804 bp LO promoter region bind with the in vitro translated HIF-1 complex. For this purpose, two subunits of HIF-1, i.e., HIF-1α and HIF-1β, were synthesized in vitro by using the reticulocyte lysate system (Promega). EMSAs were performed with the proteins obtained in unprogrammed reticulocyte lysates, HIF-1α/HIF-1β-primed reticulocyte lysates and HIF-1α/HIF-1β-primed reticulocyte lysates plus anti-HIF-1α antibody. As shown in Figure 6D , a specific complex with retarded migration appeared exclusively when HIF-1α/HIF-1β-primed lysates with anti-HIF-1α antibody were incubated together with the labeled HRE-3 probe (lane 9). No complex was visualized when labeled HRE-1, HRE-2, or HRE-4 was used as the probe (Fig. 6D) . These data further demonstrate that HIF-1 complex binds to the consensus HRE-3 located at the proximal promoter region of the LO gene.
Mutational Analysis of the HRE-3 Within 804 bp of the LO Promoter
To assess the functional importance of the HRE-3 element in the proximal promoter region of the LO gene, this sequence was mutated in the pLOProm 804 reporter vector (Fig. 7A) .
FIG. 4.
Association of upregulation of HIF-1α and LO at mRNA levels in RFL6 cells treated with Co. Growth-arrested cells were incubated for 24 h in 0.3% FBS/DMEM in the absence (lanes 1-5) or presence (lanes 6-10) of 100 µM Co. Total RNA was extracted from cells using TRIzol reagent. Transcript levels of HIF-1α (lanes 1 and 6), HIF-1β (lanes 2 and 7), DN-HIF-1α (lanes 3 and 8), LO (lanes 4 and 9), and GAPDH (lanes 5 and 10), an internal control, in control (lanes 1-5) and treated cells (lanes 6-10) were determined by RT-PCR. M, molecular ladder.
FIG. 5.
The schematic linear map of HRE consensuses in the cloned rat LO promoter. ATG, the translational start site; ACGTG or CACGT, the core HRE consensuses sequence; regions such as −387/−383 indicating the fragments between two nucleotide numbers using the first nucleotide preceding the ATG codon as −1. solid light blue line box, functionally active HRE consensuses; dash line boxes, nonfunction HRE consensuses; the green lines in the consensuses box, the HRE in the noncoding strand; and the light green lines in the coding strand; the red lines with orange boxes, coding regions. 32 P]ATP and incubated with nuclear protein isolated from control (NE), Co-treated cells (NECO), or bovine serum albumin (BSA), a negative control, as described in Materials and Methods section. After reaction, samples were subjected to native 6% polyacrylamide gel electrophoresis and visualized by exposure of the dried gel to Kodak film. (C) Competition EMSA. Cold synthetic human Epo HRE oligonucleotide with high affinity for the HRE (see Materials and Methods section) at 100-fold molecular excess was added 10 min prior to addition of the radiolabeled probe. After reaction, gels were run as described above in B. (D) Supershift EMSA to assess DNA probe binding with in vitro transcription/translation HIF-1 proteins. Reaction mixtures contain 2 µg in vitro transcription/translation proteins, HIF-1α and HIF-1β each. Supershift reactions were run as described above in B with the exception that 2 µg of a specific antibody against HIF-1α was added 10 min prior to addition of labeled probes.
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The HRE wild-type or mutated construct and the pRL-TK vector, an internal control, were transiently cotransfected into RFL6 cells followed by treatment with or without 100 µM Co. As shown in Figure 7 , in the wild-type LO HRE promoter, the luciferase activity was increased to 2.5-fold of the control in the presence of Co. In contrast, in the HRE element-mutated LO promoter, the luciferase activity was reduced to 53.2% of the no mutation control in RFL6 cells incubated under same conditions. These results support the conclusion that the HRE-3 consensus sequence is required for hypoxia-mediated induction of LO promoter activity.
HIF-1α Binding to the LO HRE-387/-383 in RFL6 Cells in Response to Co and Cd
To identify effects of oxidative stress on Co activation of the LO HRE, we examined HIF-1α binding to the LO gene in Co-treated RFL6 cells in response to Cd, a ROS inducer (Cuypers et al., 2010) . CdR cells (Zhao et al., 2006) were also used as a long-term Cd exposure model in this study. HIF-1α binding to the LO HRE-387/-383 was determined in cell models by ChIP assays as described (Gao et al., 2007) . RNA-Poly II binding to the GAPDH gene was included as an internal control. As demonstrated above (Fig. 6) , there was at least one functionally active HRE located at the regions −387/−383 in the LO promoter region −804/−1 that displayed the maximal promoter activity. As shown in Figure 8A , approximately, a 150-bp band was observed on the gel as the chromatin-protein crosslinked by formaldehyde fixation, immunoprecipitated with the HIF-1α antibody, and PCR-amplified using the primer pair that encompasses the HRE −387/−383 in cells treated with 100 µM Co alone (lane 3). In contrast, no signal was detected in control cells without any treatment, cells treated with 5 µM Cd alone, and cells treated with 100 µM Co plus 5 µM Cd. Cd at 5 µM was used in this study because this concentration of Cd has been shown to inhibit LO at mRNA, protein, and catalytic levels (Li et al., 1995; Zhao et al., 2010) . Furthermore, HIF-1α in the long-term Cd exposure model, CdR cells, exhibited a weak binding activity for the LO HRE in cells response to Co. The HIF-1α binding to the LO HRE levels was decreased to 72, 63, and 7% of the control in CdR20, CdR40, and CdR80 cells, respectively, in response to 100 µM Co (Fig. 8C ). In parallel, as an internal control, the RNA-Poly II binding to the GAPDH gene was not significantly changed in cells incubated under same corresponding conditions. No band was found in the gels using the samples immunoprecipitated by nonspecific IgG, and there was no significant difference in the yields of PCR products among groups using "input" (before immunoprecipitation) DNA as a template (data not shown). These results indicated that (1) Co stimulated HIF-1α binding to the LO HRE and (2) Cd inhibited LO HRE activation elicited by Co in RFL6 cells. Thus, the status of cellular HIF-1α binding to the LO gene −387/−383 is specific and highly sensitive to modification of Cd.
Cd Effects on HIF-1α mRNA Expression Elicited by Co
Cells exposed to Co displayed upregulation of HIF-1α mRNA (Fig. 4) . To further assess Cd effects on the Co-elicited HIF-1α expression, cells were treated with or without Co, Cd or both, or CdR cells with different degree of Cd resistance treated with Co alone. Then, total RNA were extracted from cell models, converted to the cDNA for each sample, and amplified by RT-PCR as described (Chen et al., 2005) . As shown in Figure 9A , Cd induced a dose-dependent inhibition of Co-stimulated HIF-1α expression. Levels of HIF-1α mRNA were decreased to 47, 28, and 16% of the control, respectively, in 100 µM Co-treated cells coincubated with 1, 3, and 5 µM Cd. Furthermore, CdR20, CdR40, and CdR80 cells also exhibited a reduced HIF-1α mRNA levels in response to 100 µM Co, amounting to 48, 20, and 14 of the RFL6 control, respectively (Fig. 9B) . These results provide strong evidence for Cd inhibition of Co-stimulated LO HRE activation at the HIF-1α mRNA levels. METAL REGULATION OF LYSYL OXIDASE GENE HRE defined as hypoxia occurring under physiological and pathological conditions (Kaluz et al., 2008) . Hypoxia-responsive genes contain the cis-acting element called the "HRE" with the core sequence 5′-RCGTG-3′ (R = purine), which in most cases is 5′-ACGTG-3′. Currently, functionally active HREs have been identified in the promoter region of more than 100 mammalian genes involved in erythropoiesis, glycolysis, angiogenesis, carcinogenesis, and other biological activities (Manalo et al., 2005; Semenza, 2010) . Here, as reported by us, the rat LO gene is highly responsive to hypoxia as evidenced by increased mRNA expression in RFL6 cells exposed to Co, a chemical hypoxia reagent (Fig. 1A) . Furthermore, Co exposure significantly enhanced LO promoter-driven reporter (luciferase) activities in cells cotransfected without (Fig. 1B) or with HIF-1 expression vectors (Fig. 2) . The rat LO promoter region -804/-1 contains four putative HREs (Fig. 5) . Using both the Co-treated cell nuclear extract (Fig. 6B ) and the in vitro synthetic HIF-1 (Fig. 6D) as ligands, EMSA assays demonstrated that there is only one active HRE at -387/-383 for HIF-1 binding in the LO promoter −804/−1. Moreover, nonlabeled probe competition (Fig. 6C ) and point mutation (Fig. 7) assays illustrated the specificity of this active site. These results suggest that the core HRE is important, but not unique, for the gene activation by hypoxia because several identical core HRE consensuses such as -37 /-33, -194/-190, and -457/-453 in the rat LO promoter failed to bind with HIF-1 (Figs. 6B and D) . In agreement with our findings, nonfunctional core HREs were also detected in other genes (Kaluz et al., 2008) . Thus, it would seem reasonably to assume that in addition to the core HRE, the variable flanking sequences located at both sides of the core HRE (−387/−383) may also play a critical "helper" role in Co activation of the LO gene.
The HIF-1 is a major HRE binding protein composed of HIF-1α and HIF-1β subunits, of which HIF-1α acts as a key sensor for hypoxia (Kaluz et al., 2008) . The HIF-1α contains a unique O 2 -dependent degradation domain (ODDD). Under normoxic conditions, enzymatic hydroxylation of two prolines within ODDD leads to degradation of the HIF-1α by the proteasome. The proline hydroxylation is catalyzed by prolyl hydroxylase domain proteins (PHDs) including PHD1, PHD2, and PHD3 (Bruick and McKnight, 2001 ). In the reaction, PHDs using Fe(II) and ascorbate as cofactors split molecular oxygen and transfer one oxygen atom to the proline residue (Ke and Costa, 2006) . Thus, PHDs function as intracellular oxygen sensors providing the molecular basis for regulation of HIF-1α protein expression by cellular O 2 partial pressure. Upon hypoxia, inactivation of PHDs results in cellular accumulation of HIF-1α, which is then translocated into the 386 nucleus, coupled with HIF-1β, and bound to HREs for transactivating hypoxia-inducible genes. The HIF family contains three α subunits (1α, 2α, and 3α) and two β units (ARNT and ARNT2) (Nakayama, 2009 ). In addition, several alternatively spliced variants have also been identified. The DN-HIF-1α variant such as lacking exons 11 and 12 displayed severely damaged transcriptional activity (Chun et al., 2002) . Note that in this study, the DN-HIF-1α was used as a tool to identify the specificity of the activation of the LO HRE by Co-induced hypoxia (Fig. 3) .
The direct link and overlap of gene expressions and signal transcriptional patterns between hypoxia and Co exposure have led to use this metal ion as the mimic of hypoxia in the biological research (Epstein et al., 2001) . Co ion as a chelator can compete with the nonhemo iron for binding to the active site of PHDs and deplete ascorbate, two cofactors of PHDs, thus inhibiting PHD catalytic activity and subsequently stabilizing the HIF-1α protein (Epstein et al., 2001; Salnikow et al., 2004) . It should be noted that in the RFL6 cell model as shown in this study, cobaltous ion not only increased HIF-1α protein levels in nuclear extracts (compare lane 9 with lane 8 in Fig. 6B ) but also enhanced HIF-1α gene expression at mRNA levels (Fig. 9) . Co-enhanced expression of the HIF-1α gene has been proposed by activation of the PI3-kinase/Akt pathway (Ardyanto et al., 2006) . Importantly, Co stimulation of the HIF-1α expression at protein and mRNA levels (Figs. 6B and 9) was associated with upregulation of LO (Fig. 4) . Moreover, Co enhanced the HIF-1α binding to the LO HRE −387/−383 in RFL6 cells (Fig.  8) . These results strongly support the conclusion that the activation of the HRE by HIF-1 plays a critical role in Co upregulation of LO (Fig. 1A) .
Co is an essential metal, but overexposure of human to this metal compounds induces diseases in different organs (EPA, 2000) . Co-elicited hypoxia response is implicated in lung toxicity and pathology (Cugell, 1992; Saini et al., 2010) . DNA microarray studies established the causal links between hypoxia and fibrosis. Hypoxia activated a striking number of genes relevant to the fibrogenic pathogenesis including collagens and its modulating enzymes in pulmonary endothelial cells (Manalo et al., 2005) . In this study, we further identified Co activation of the LO gene in rat lung fibroblasts via the HIF-1 pathway. LO is an amine oxidase critical for lung morphogenesis and tissue repair. It initiates the covalent crosslinking of collagen and elastin by oxidizing specific lysine residues in these proteins stabilizing the lung ECM (Li et al., 2011) . As hypoxia mimics, Co compounds have been evaluated as a Group 2A or a Group 2B human carcinogen by IARC (Rousseau et al., 2005) . Hypoxia is associated with lung solid tumors such as non-small cell lung cancer. Patients with high tumoral LO expression had significantly lower survival compared with those with low-expressing tumors (Le et al., 2007) . Upregulation of LO facilitated hypoxia-induced epithelial-mesenchymal transition in different tumor cell lines (Sahlgren et al., 2008) and enhanced hypoxia-induced tumor cell migration and invasion (Erler et al., 2006) . Thus, findings that Co activated the LO gene through the HIF-1 pathway provide a critical basis for understanding mechanisms for Co-induced lung fibrosis and cancer progression.
Cd is a toxic metal, but still widely used in industries. In addition to occupational exposure, cigarette smoke constitutes a major source of Cd exposure for humans (IARC, 1993) . The lung is a major Cd-target organ with a biological half-life of 9.4 years (IARC, 1993) . Long-term exposure to Cd resulted in emphysema (Davision et al., 1988) . Pulmonary Cd levels in smokers with severe emphysema pathology reached 7.5-fold greater than those in nonsmokers (Pääkkö et al., 1989) . Thus, Cd was listed by the U.S. Environmental Protection Agency as one of the 126 priority pollutants (National Toxicology Program, 2000) . Our previous studies indicated that Cd exposure induced downregulation of LO and its substrates (collagen and elastin) in Cd-pulsed cells and in CdR cells (Zhao et al., 2006) . Furthermore, such relationship of Cd exposure with downregulation of LO, collagen, and elastin was also confirmed in emphysematous lungs of the rat animal model (Zhao et al., 2010) . Cd is a ROS inducer (Cuypers et al., 2010) , whereas HIF-1α is a hypoxia sensor transcription factor (Kaluz et al., 2008) . Cd inhibition of HIF-1 expression and gene targeting METAL REGULATION OF LYSYL OXIDASE GENE HRE has been assessed in other genes such as EPO in response to hypoxia or Co (Horiguchi et al., 2000; Obara et al., 2003) . Cd blocks the expression of hypoxia-responsive genes by enhancement of proteasome-dependent degradation of HIF-1α (Chun et al., 2000) . In contrast, the contradictory report indicated Cd elevation of HIF-1 expression through ROS, ERK, and AKT pathways inducing malignant transformation of human bronchial epithelial cells (Jing et al., 2012) . Hypoxia is an important complication associated with lung diseases and tumors (Weissmann, 2008) . Reduced expression of HIF-1α has been determined in the emphysema lung tissues in severe COPD patients (Yasuo et al., 2011) , suggesting that deregulation of HRE activities may occur in HIF-1α targeting genes such as LO under this condition. Cd-inhibited Co activation of the LO gene via modulation of the HIF-1α targeting in this study is consistent with the endpoint for Cd-induced downregulation of LO, which acts as a key mechanism for Cd emphysema pathology.
Briefly, in this study, we identified (1) a unique active HRE located at −387/−383 in the rat LO gene promoter using Co as a hypoxia mimic, (2) Co enhanced the expression of the LO gene through activation of the HIF-1 gene and its binding to the HRE in the LO gene in rat lung fibroblasts, and (3) Cd abolishment of Co biological activity toward HIF-1. These results are expected to enhance our understanding of mechanisms for Co-induced lung fibrosis and cancers and Cd-induced emphysema.
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